Skin grafting

1. High-Yield Summary

• Biological Independence and Three-Phase Take: Skin grafting involves complete detachment of cutaneous tissue (epidermis and variable dermis) from donor vascularity, requiring an uninterrupted three-phase sequence for survival: plasmatic imbibition (0 to 48 hours; passive nutrient diffusion, 30% to 40% weight gain), inosculation (48 to 72 hours; direct microvascular alignment and kissing vessel anastomoses), and angiogenic capillary ingrowth with lymphatic restoration (day 4 to 7).
• Absolute Recipient Bed Requirements: Skin grafts require a highly vascularized soft tissue bed (viable muscle, bleeding periosteum, intact paratenon, or healthy granulation tissue). Grafts will fail completely over avascular bare cortical bone stripped of periosteum, necrotic tendon lacking paratenon, exposed hardware, or infected tissue beds with bacterial bioburden exceeding 10^5 colony-forming units per gram of tissue or any presence of Streptococcus pyogenes.
• Split-Thickness (STSG) versus Full-Thickness (FTSG) Dynamics: STSG (0.008 to 0.018 inches; 0.20 to 0.45 mm) exhibits lower primary contraction, higher secondary contraction (30% to 60%), lower metabolic requirements, and superior take on marginal beds, while leaving dermal appendages in the donor site for spontaneous re-epithelialization in 7 to 14 days. FTSG (full dermis) undergoes marked primary recoil (30% to 40%) and minimal secondary contraction (<10%), providing superior durability, pigmentation match, and joint mobility across flexion creases, but requires pristine vascularity and primary donor site closure.
• Negative Pressure Wound Therapy (NPWT) Bolster Standard: Contemporary Level I evidence confirms that continuous NPWT bolsters (-75 to -125 mmHg) over a non-adherent contact interface achieve significantly higher graft take rates (odds ratio 2.45) and lower reoperation rates compared to traditional tie-over bolsters by eliminating dead space, conforming to complex topography, draining serosanguinous exudate, and neutralizing micro-shear forces.
• Reconstructive Ladder and Staged Optimization: Skin grafting must not serve as an empirical shortcut over inadequately prepared beds. Traumatic soft tissue defects with exposed bone or tendon require either staged bed optimization (radical debridement, cortical fenestrations/burring, dermal regeneration templates, and NPWT) or progression to local, regional, or microvascular free tissue transfer.

2. Anatomy

A comprehensive understanding of cutaneous microarchitecture, dermal vascular plexuses, and regional donor anatomy dictates graft selection, harvesting depth, and recipient bed preparation in orthopaedic reconstructive surgery.

Microanatomy of Epidermis and Dermis

• Epidermal Stratification: Stratified squamous keratinized epithelium consisting of five distinct strata: stratum basale (proliferative stem cells, melanocytes, and Merkel tactile cells anchored to the basement membrane via hemidesmosomes), stratum spinosum (polyhedral keratinocytes with prominent desmosomal junctions and dendritic Langerhans cells), stratum granulosum (keratohyalin granules releasing profilaggrin), stratum lucidum (clear transitional layer present exclusively in thick glabrous skin of palms and soles), and stratum corneum (densely packed anucleated corneocytes embedded in a lipid matrix). Total epidermal thickness ranges from 0.05 mm on the eyelids to 1.5 mm on palmar and plantar skin.
• Dermal-Epidermal Junction (DEJ): Characterized by an undulating microarchitecture of epidermal rete ridges interdigitating with dermal papillae. This interlocking geometry expands surface area for diffusion-based nutrient exchange and provides mechanical resistance against horizontal shear stresses. Basement membrane anchoring is mediated by hemidesmosomes, type IV collagen in the lamina densa, laminin-332, and type VII collagen anchoring fibrils extending into the papillary dermis.
• Papillary Dermis: Superficial, delicate zone of loose connective tissue rich in type III collagen, amorphous ground substance, Meissner tactile corpuscles, and vertical capillary loops directly supplying the avascular epidermis.
• Reticular Dermis: Deeper, robust structural layer composed of thick, parallel bundles of type I collagen oriented along relaxed skin tension lines (Langer lines), high-density elastin fibers providing tensile strength and elastic recoil, and pacinian corpuscles.
• Epithelial Adnexal Reservoirs: Hair follicles, sebaceous glands, and eccrine/apocrine sweat glands are lined by epithelial cells continuous with the basal epidermis. Because these structures extend deep into the reticular dermis and superficial subcutaneous fat, their retained epithelial lining serves as the regenerative stem cell reservoir for spontaneous re-epithelialization of split-thickness donor sites.

Dermal Vascular Plexuses

• Subpapillary (Superficial) Vascular Plexus: Located at the junction of the papillary and reticular dermis, giving off terminal capillary loops that ascend into individual dermal papillae to nourish the overlying epidermis.
• Deep (Subdermal/Reticular) Vascular Plexus: Positioned at the junction of the reticular dermis and subcutaneous adipose tissue, characterized by larger-diameter arterioles and paired venules supplied by terminal branches of musculocutaneous or septocutaneous perforator arteries.
• Communicating Vessels: Vertical bridging arterioles and venules connect the deep and superficial plexuses, regulated by glomus bodies and specialized arteriovenous anastomoses involved in thermoregulation and microvascular perfusion.

Donor Sites and Anatomical Selection

• Anterolateral and Lateral Thigh (STSG): Workhorse donor site in orthopaedic trauma reconstruction due to broad surface area, flat contour, ease of concealment, and low mobility during ambulation.
• Buttocks and Upper Gluteal Region (STSG): Excellent concealment and thick dermis, though nursing care and prone or lateral positioning may be required.
• Medial Arm and Abdominal Wall (STSG): Alternative donor sites when lower extremities are compromised by trauma, burn injury, or severe peripheral vascular disease.
• Inguinal Crease / Groin (FTSG): Abundant cutaneous reservoir allowing primary linear closure concealed within the pelvic skin fold; ideal for large palmar and digital hand defects.
• Hypothenar Eminence (FTSG): Glabrous skin donor site for volar digital resurfacing, matching the thick stratum corneum, fibrous septa, and durable texture of the hand.
• Pre-auricular, Post-auricular, and Supraclavicular Fossa (FTSG): Optimal color, thickness, and solar elastosis match for head and neck reconstruction.
• Antecubital Fossa and Lower Abdominal Transverse Crease (FTSG): Supple, mobile donor options for upper extremity joint contracture releases.

Anatomical Structures at Risk and Danger Zones

• Lateral Femoral Cutaneous Nerve (LFCN): Arises from the L2-L3 nerve roots, emerges beneath the lateral aspect of the inguinal ligament medial to the anterior superior iliac spine (ASIS), and crosses over or through the sartorius muscle into the thigh. When harvesting split-thickness grafts from the anterolateral thigh, excessively deep harvesting into subcutaneous fat or aggressive high-pressure tumescent infiltration can contuse or transect the nerve, resulting in painful meralgia paresthetica or permanent lateral thigh anesthesia.
• Femoral Neurovascular Bundle: In full-thickness graft harvesting from the groin, dissection must remain strictly superficial to the fascia lata and scarpa fascia. The femoral artery, vein, and nerve lie medial to the ASIS within the femoral triangle; excessively deep dissection risks catastrophic vascular laceration.
• Ulnar Neurovascular Structures at Hypothenar Donor Site: When harvesting hypothenar FTSG, incisions must remain strictly superficial to the abductor digiti minimi fascia to prevent laceration of the proper digital branch to the small finger or injury to the deep motor branch of the ulnar nerve as it passes between the abductor and flexor digiti minimi brevis.
• Paratenon and Periosteum Preservation: In the extremities, paratenon (the vascularized, loose connective tissue sheath enclosing extra-synovial tendons such as the Achilles and extensor digitorum) and periosteum (the osteogenic, vascularized membrane enclosing cortical bone) represent the sole vascular beds capable of supporting skin graft take. Accidental stripping of paratenon or periosteal denudation during wound debridement converts an graftable wound into an avascular defect that demands flap reconstruction or staged dermal matrix coverage.

3. Pathogenesis & Biological Basis of Take

The successful biological incorporation (“take”) of a skin graft is an orchestrated physiological continuum divided into three sequential phases, governed by microvascular physics and tissue remodeling kinetics.

The Three Phases of Graft Revascularization

• Phase 1: Plasmatic Imbibition (Hours 0 to 48): During the initial 48 hours following detachment, the graft is entirely avascular and relies completely on passive diffusion of nutrients, dissolved oxygen, and electrolytes from the underlying recipient bed exudate. Graft capillary beds remain open by capillary action, absorbing fluid, serum proteins, and electrolytes, causing the graft to gain 30% to 40% in total weight during this initial edematous period. A provisional fibrin matrix polymerizes between the recipient bed and the graft dermis, functioning as an adhesive anchor and structural lattice for cellular migration. Any fluid collection exceeding 0.5 mm in thickness creates an insurmountable barrier to diffusion, resulting in ischemic necrosis of the overlying graft.
• Phase 2: Inosculation (Hours 48 to 72): Pre-existing, severed capillary lumina within the donor dermis align and establish direct physical anastomoses with budding endothelial capillary sprouts arising from the recipient bed (“kissing vessels”). Primitive erythrocyte flow is established across these microvascular junctions, initially appearing as sluggish, non-pulsatile perfusion. Clinically, the graft transitions from its initial ischemic, blanched white appearance to a mottled pink or light violaceous hue, confirming early vascular communication.
• Phase 3: Revascularization and Angiogenesis (Day 4 through Day 7 and Beyond): True neovascularization occurs through active endothelial cell proliferation and direct angiogenic ingrowth, forming entirely new capillary networks that invade the donor dermis. Maturing vascular channels undergo lumenization and pericyte recruitment, establishing organized directional microcirculation. Lymphatic channels re-establish continuity by postoperative day 5 to 7, allowing drainage of trapped interstitial fluid and resolution of graft edema. Fibroblastic ingrowth replaces the provisional fibrin network with organized extracellular matrix, synthesizing type III and type I collagen to establish permanent mechanical shear resistance.

Biomechanics of Primary versus Secondary Contraction

• Primary Contraction (Immediate Harvest Recoil): Driven entirely by the passive recoil of elastin fibers situated within the reticular dermis immediately upon releasing the skin from surrounding tension. Primary contraction is directly proportional to the volume of reticular dermis harvested. A full-thickness skin graft contracts by 30% to 40% in surface area immediately upon excision, whereas a thin split-thickness graft (containing minimal reticular dermis) contracts by less than 10%.
• Secondary Contraction (Maturation Wound Cicatrization): Driven actively by myofibroblasts at the graft-recipient bed interface. Myofibroblasts express alpha-smooth muscle actin (alpha-SMA) and exert continuous inward contractile vectors on the surrounding collagen matrix during wound remodeling. Secondary contraction is inversely proportional to the volume of dermis present in the graft. A thick dermis acts as a physical and biochemical buffer, inhibiting myofibroblast differentiation and counteracting wound bed contraction. Thin STSGs undergo dramatic secondary contraction (30% to 60% surface area reduction), often resulting in severe joint contractures, whereas FTSGs undergo minimal secondary contraction (<10%), preserving joint arc of motion and contour.

Primary Mechanisms of Graft Failure

• Hematoma and Seroma Formation: Accumulation of fluid separates the graft from the recipient bed. Because oxygen and glucose diffusion cannot exceed 0.5 mm, an intervening fluid layer leads to rapid graft ischemia and necrosis.
• Micro-Shear Vectors: Tangential motion between the graft and the bed disrupts delicate fibrin bridges during hours 0 to 48 and tears newly forming capillary inosculations during hours 48 to 72.
• Bacterial Bioburden and Enzymatic Lysis: High concentrations of bacterial pathogens release bacterial collagenases, elastases, and proteases that digest the provisional fibrin matrix and destroy endothelial buds.

4. Natural History & Epidemiology

Soft tissue loss in orthopaedic surgery results from traumatic injury, post-surgical release, or radical debridement. Understanding the natural course of unresurfaced open wounds highlights the necessity of timely, definitive coverage.

Etiologies in Orthopaedic Trauma and Reconstruction

• High-Energy Open Fractures: Extensive cutaneous deficits associated with Gustilo-Anderson Type IIIA and converted Type IIIB fractures, where underlying skeletal stability and muscular coverage are achieved but overlying skin is lost.
• Fasciotomy Wounds in Acute Compartment Syndrome: Decompression of tibial fractures, crush injuries, and forearm trauma via dual-incision leg or volar forearm fasciotomies frequently leads to skin edge retraction and muscle edema, preventing primary closure and necessitating STSG coverage.
• Traumatic Degloving Injuries and Morel-Lavallée Lesions: High-energy shear forces detach skin and subcutaneous tissue from deep muscular fascia. Avulsed or unviable skin flaps must be debrided, thinned, and re-applied as full- or split-thickness grafts if the recipient bed is viable.
• Free and Pedicled Flap Donor Sites: Resurfacing muscle or fasciocutaneous donor sites, including latissimus dorsi, anterolateral thigh (ALT), and fibula osteocutaneous flap sites.
• Post-Infectious and Oncologic Debridements: Soft tissue deficits following radical resection of necrotizing soft tissue infections, deep periprosthetic infections, or soft tissue sarcomas.

Natural History of Unresurfaced Soft Tissue Defects

• Chronic Bacterial Colonization and Biofilm Shift: Open granulating wounds left to heal by secondary intention develop thick, persistent biofilms populated by resistant nosocomial pathogens (MRSA, Pseudomonas aeruginosa, Acinetobacter baumannii). Bacterial persistence promotes chronic osteomyelitis of underlying bone and chronic periprosthetic infection.
• Uncontrolled Myofibroblastic Contracture: Secondary intention healing across flexion or extension creases of the knee, ankle, elbow, or wrist leads to dense scar bands, joint subluxation, fixed deformities, and severe loss of functional range of motion.
• Marjolin Ulcer Transformation: Chronic, unhealed, or unstable burn and traumatic scars subjected to cycles of repeated ulceration and delayed healing over decades (typically 20 to 30 years) carry a recognized 1% to 2% lifetime risk of malignant transformation into aggressive, metastatic squamous cell carcinoma (Marjolin ulcer).

Donor Site and Recipient Bed Healing Timelines

• STSG Donor Sites: Re-epithelialization proceeds radially from the residual epithelial lining of deep hair follicles and sweat ducts. Thin STSG donor sites re-epithelialize within 7 to 10 days; medium STSG donor sites require 10 to 14 days; thick STSG donor sites require 14 to 21 days and carry a substantial risk of donor site hypertrophic scarring.
• Recipient Bed Graft Integration: Complete microvascular inosculation and capillary ingrowth occur by day 7 to 10. Epidermal turnover stabilizes over 3 to 4 weeks. Dermal collagen remodeling, vascular maturation, and tensile strength stabilization continue for 6 to 12 months.

5. Clinical Presentation

Preoperative clinical evaluation requires a dual assessment: determining host biological capacity for wound healing and scrutinizing the microstructural characteristics of the recipient wound bed.

History

• Traumatic Mechanism and Wound Chronology: Document the exact mechanism (crush, blast, high-speed friction, degloving, burn, or open fracture). Determine the exact elapsed time from injury, contamination history, previous surgical debridements, and prior negative pressure dressing settings.
• Tobacco and Nicotine Use: Nicotine triggers severe cutaneous vasoconstriction, decreasing microvascular perfusion by up to 40% for 90 minutes per cigarette, while carbon monoxide displaces oxygen from hemoglobin, severely impairing plasmatic imbibition.
• Diabetes Mellitus: Elevated hemoglobin A1c (>8.0%) causes advanced glycation end-product (AGE) accumulation, capillary basement membrane thickening, impaired neutrophil phagocytosis, and blunted angiogenic sprouting.
• Peripheral Arterial Disease (PAD): Claudication, rest pain, prior revascularization, or absent distal pulses significantly increase graft failure risk.
• Chronic Venous Insufficiency: Venous hypertension, stasis dermatitis, and pericapillary fibrin cuffing limit oxygen diffusion and promote edema.
• Nutritional Deficiencies: Serum albumin (<3.0 g/dL) or prealbumin (<15 mg/dL) deficiency impairs fibroblast proliferation and collagen synthesis.
• Immunosuppressive Medications: Systemic corticosteroids, anti-TNF biologics, and chemotherapy inhibit inflammatory cascades essential for early wound healing.

Physical Exam

• Granulation Bed Quality: Healthy, graftable granulation tissue appears beefy red, firm, finely granular, non-friable, and slightly moist. Unfavorable granulation tissue appears pale, glassy, gelatinous, hypergranulating (exuberant), or dark purple/violaceous (congested).
• Substrate Anatomical Assessment: Verify whether the bed consists of viable muscle, subcutaneous fascia, bleeding periosteum, or intact paratenon.
• Avascular Substrates: Meticulously inspect for bare cortical bone stripped of periosteum, exposed tendon devoid of paratenon, exposed cartilage, or bare metal hardware. None of these substrates can support graft take.
• Periwound Environment: Assess for edge maceration, induration, and periwound erythema extending >2 cm from the margin (indicating invasive cellulitis).
• Bioburden Signs: Evaluate for thick slough, foul odor, or greenish-blue purulent exudate indicative of Pseudomonas aeruginosa.
• Peripheral Perfusion Metrics: Palpate distal pulses (dorsalis pedis, posterior tibial, radial, ulnar) and measure capillary refill time (<2 to 3 seconds).
• Capillary Bleeding Scratch Test: Gently abrading granulating wound bed with 15-blade or gauze edge -> Punctate, uniform capillary bleeding within 3 to 5 seconds indicates sufficient microvascular perfusion for graft imbibition [Sensitivity ~88%, Specificity ~85%].
• Probe-to-Bone Test: Probing base of ulcer/defect with sterile blunt metallic probe -> Hard, gritty metallic stop on exposed cortical bone indicates periosteal denudation and high probability of underlying osteomyelitis or avascular bed [Sensitivity 87%, Specificity 91%].
• Periwound Skin Turgor and Edema Test: Applying 5 seconds of digital pressure 2 cm from wound margin -> Persistent pitting edema indicates microvascular venous congestion and elevated interstitial pressure that impairs inosculation [Sensitivity ~82%, Specificity ~79%].

6. Imaging and Diagnostic Studies

Diagnostic evaluation aims to confirm skeletal stability, evaluate macrovascular and microvascular perfusion, and rule out deep infection or retained foreign material prior to reconstruction.

Diagnostic Modalities and Perfusion Metrics

• Standard Plain Radiography: Anteroposterior (AP) and lateral orthogonal views of the involved extremity are mandatory. Verify osseous alignment and rigid fracture fixation; detect radiopaque foreign bodies (glass, gravel, metal fragments); identify soft tissue gas indicating necrotizing infection; and rule out chronic osteomyelitis (periosteal reaction, cortical sequestrum, or involucrum formation).
• Ankle-Brachial Index (ABI): Normal 0.90 to 1.30. An ABI < 0.60 indicates critical arterial insufficiency; skin grafting without prior revascularization carries a failure rate >70%. An ABI > 1.30 indicates non-compressible, calcified arteries (Mönckeberg sclerosis) in diabetic or renal disease, requiring toe pressure measurement.
• Toe-Brachial Index (TBI) and Absolute Toe Pressure: Normal TBI > 0.70. Absolute toe systolic pressure > 40 mmHg (or TBI > 0.60) is predictive of successful microvascular healing and skin graft take.
• Transcutaneous Oxygen Tension (TcPO2): Measures the partial pressure of oxygen diffusing through the skin from dermal capillaries. A baseline TcPO2 > 40 mmHg indicates adequate local tissue oxygenation for graft survival; TcPO2 < 30 mmHg correlates strongly with graft necrosis and chronic non-healing.
• Computed Tomography Angiography (CTA) and Conventional Angiography: Indicated in high-energy trauma (Gustilo-Anderson IIIB/IIIC open fractures, knee dislocations, crush injuries) to identify vascular injury, multi-level arterial occlusions, or pseudoaneurysms, and to confirm three-vessel run-off to the foot or dual-vessel run-off to the hand.
• Indocyanine Green (ICG) Fluorescence Angiography: Near-infrared imaging following intravenous injection of ICG provides real-time quantitative assessment of recipient bed microvascular perfusion and demarcates non-viable or under-perfused margins requiring debridement.
• Quantitative Wound Cultures and Tissue Biopsy: Superficial swab cultures capture non-pathogenic surface colonizers and are inadequate for surgical planning. Quantitative tissue biopsy is the diagnostic gold standard: a full-thickness tissue punch is weighed, homogenized, and cultured quantitatively. A bacterial load exceeding 10^5 colony-forming units (CFU) per gram of tissue triggers graft lysis and is a contraindication to grafting. Any quantitative presence of Beta-hemolytic Streptococcus (Streptococcus pyogenes) produces streptokinase and hyaluronidase that completely dissolves fibrin bridges, causing 100% graft failure regardless of bacterial count.

7. Classification

Skin grafts are classified according to the depth of harvested dermis (thickness), their tissue composition, and their structural configuration (sheet versus meshed).

Structural Configuration: Sheet versus Meshed Grafts

8. Treatment

Successful skin grafting requires methodical wound bed preparation, precise graft harvesting technique, robust mechanical fixation, and adherence to evidence-based postoperative dressing protocols.

Nonoperative / Wound Bed Preparation

• Radical Surgical Debridement: The fundamental prerequisite for graft survival: all non-viable, infected, fibrotic, or foreign material must be excised back to healthy, uniform punctate capillary bleeding (“papillary blush”). Meticulous hemostasis is achieved with fine-tipped bipolar electrocautery, topical epinephrine soaks (1:100,000), or topical thrombin. Avoid extensive monopolar cauterization, which produces charred necrotic tissue that impedes plasmatic imbibition.
• Bioburden Suppression: Suppression of bacterial counts below 10^5 CFU/g and complete eradication of Streptococcus pyogenes. Wound cleansing with low-pressure pulsatile lavage or gentle bulb syringe irrigation. Topical antimicrobials include dilute sodium hypochlorite (Dakin’s solution 0.125%), polyhexamethylene biguanide (PHMB), or 0.5% acetic acid for Pseudomonas colonization. Culture-directed intravenous antibiotics treat invasive cellulitis but do not sterilize avascular surface biofilm without mechanical debridement.
• Pre-Grafting Negative Pressure Wound Therapy (NPWT): Application of open-cell reticulated polyurethane black foam at -125 mmHg continuous pressure for 3 to 7 days prior to grafting. Micro-strain stimulates endothelial proliferation and vascular endothelial growth factor (VEGF) release; macro-strain collapses dead space, reduces interstitial edema, and rapidly converts an indolent wound into a hyperemic, granulating bed.

Operative Technique & Graft Selection

• Powered Dermatome Harvesting Technique (STSG): Liberally lubricate the donor site and dermatome blade with sterile mineral oil or saline to eliminate surface drag. The surgeon and assistant establish rigid two-point counter-traction using two sterile wooden boards or tongue depressors. The assistant presses firmly 2 to 3 cm ahead of the dermatome, while the surgeon applies reciprocal traction behind it, flattening the thigh into an unyielding planar surface. Maintain the dermatome at a steady 30 to 45 degree angle to the skin. Manually verify the blade gap against a known metallic feeler gauge (such as the spine of a #10 blade, ~0.015 inches / 0.38 mm) before harvesting, rather than relying solely on the machine dial. Activate the motor at maximal RPM before skin contact; advance smoothly with gentle, uniform downward pressure without stopping, tilting, or rocking. Once the desired length is harvested, gently tilt the dermatome upward or cut the graft base sharply with a scalpel.
• Full-Thickness Skin Graft Harvesting and Defatting: Accurately template the defect dimensions using sterile foil or suture packaging, adding 10% to 15% to compensate for immediate primary contraction. Orient the template along relaxed skin tension lines in the groin or hypothenar area. Incise down to subcutaneous fat and sharply elevate the graft from the adipose layer. Wrap the graft epidermal-side down over an index finger or wooden block. Using curved tenotomy or iris scissors, sharply excise every lobule of yellow subcutaneous adipose tissue until the ivory-white, glistening reticular dermis with visible pore architecture is fully exposed. Residual fat blocks capillary inosculation and causes graft necrosis. Undermine adjacent subcutaneous tissues and close the donor site primarily in layers (absorbable deep dermal sutures followed by running subcuticular closure).
• Graft Securing and Bolstering: Inset the graft under gentle physiological tension (neither lax nor stretched) and secure the margins with interrupted 4-0 or 5-0 chromic gut, rapid-absorbing monocryl, or stainless steel skin staples spaced 5 to 10 mm apart. In sheet grafts, introduce multiple staggered 1 to 2 mm slit incisions throughout the graft body using an 11-blade to provide egress for microscopic hematomas or seromas. Apply a non-adherent fenestrated contact interface (e.g., silicone mesh, Mepitel, or porous petroleum gauze) directly over the secured graft. Cut reticulated black polyurethane foam to precisely match graft dimensions without overlapping intact skin margins. Seal with an occlusive polyurethane drape and apply continuous negative pressure at -75 to -125 mmHg. This exerts uniform three-dimensional compression, continuously clears wound exudate, and rigidly splints the graft against the bed. Alternatively, place circumferential long-tailed silk sutures and tie opposing suture limbs securely over a moist cotton bolster.
• Donor Site Management: Pack the donor bed immediately upon harvest with laparotomy sponges soaked in dilute epinephrine (1:100,000) or 1% lidocaine with epinephrine, maintaining firm manual pressure for 5 minutes. Apply modern moisture-retentive semi-permeable dressings (hydrofiber with silver, polyurethane films, or calcium alginate) rather than dry or paraffin gauze. Hydrofiber dressings absorb exudate, form a cohesive gel, maintain an optimal moist healing environment, significantly reduce patient pain, and prevent traumatic re-injury during dressing changes.

Indications & Contraindications

• Clear Clinical Indications: Clean, vascularized soft tissue defects following trauma, debridement, or oncologic resection; coverage over viable muscle, deep fascia, bleeding periosteum, and intact paratenon; fasciotomy closure in the leg, thigh, or forearm when primary closure cannot be achieved without excessive compartment tension; burn wound resurfacing and traumatic degloving reconstruction; resurfacing of pedicled or free muscle flaps (e.g., latissimus dorsi, rectus abdominis, gracilis).
• Absolute Contraindications: Bare cortical bone lacking periosteum (must either burr down to bleeding Haversian canals, apply a dermal regeneration matrix for 3 weeks, or perform flap reconstruction); denuded tendon lacking paratenon (e.g., bare Achilles tendon, bare flexor/extensor tendons will desiccate and necrose); denuded nerve lacking epineurium; exposed artificial implants, plates, or joint prostheses; active invasive infection (any presence of Beta-hemolytic Streptococcus or bacterial bioburden > 10^5 CFU/g); severe limb ischemia (unrevascularized peripheral arterial disease with ABI < 0.50 or TcPO2 < 30 mmHg).
• Relative Contraindications: Active heavy tobacco smoking (requires immediate cessation protocol or delay of elective coverage); poorly controlled diabetes mellitus (HbA1c > 8.5% with microangiopathy); major mobile flexion/extension joint creases (thin or standard meshed STSGs placed across the popliteal fossa, antecubital fossa, palmar wrist, or axilla will undergo severe secondary contracture; FTSG, local tissue rearrangement, or flap coverage is preferred).

9. Outcome

Clinical outcomes after skin grafting depend upon graft take rates, functional range of motion preservation, neurosensory recovery, and donor site morbidity.

Graft Take and Revascularization Metrics

• Graft Take Rates: Contemporary clinical trials demonstrate split-thickness skin graft take rates of 92% to 98% when placed on clean, vascularized beds secured with negative pressure wound therapy bolsters, compared to 75% to 85% with traditional tie-over bolsters.
• Full-Thickness Integration: Full-thickness grafts achieve 90% to 95% take rates in small, pristine, well-vascularized defects (e.g., hand and digits), but failure rates increase precipitously (>30%) if applied over contaminated, irregular, or marginal beds.

Functional Outcomes and Patient-Reported Metrics

• Upper Extremity Outcomes: Evaluated via the Disabilities of the Arm, Shoulder, and Hand (DASH/QuickDASH) score and Michigan Hand Outcomes Questionnaire (MHQ). Patients resurfaced with FTSG or unmeshed sheet STSGs over dorsal or volar hand defects demonstrate significantly better grip strength, web space preservation, and lower DASH disability scores than those treated with widely meshed STSGs.
• Lower Extremity Outcomes: Evaluated via the Lower Extremity Functional Scale (LEFS) and Foot and Ankle Ability Measure (FAAM). Fasciotomy defects and calf defects closed with STSG achieve high LEFS scores (>70/80) provided adjacent joint contractures are prevented with early physical therapy and splinting.

Sensory Reinnervation and Adnexal Function

• Reinnervation Kinetics: Neurosensory recovery begins at 4 to 6 weeks postoperatively via collateral sprouting from surrounding normal skin borders and ascending nerve regeneration from the recipient bed, continuing for up to 18 to 24 months.
• Sensory Hierarchy: Sensory recovery follows a strict physiological sequence: deep pain and temperature sensation recover first, followed by crude touch, light touch, and lastly two-point discrimination.
• STSG Sensory Limitations: Sensation remains blunted; two-point discrimination rarely recovers, though protective sensation is achieved in 60% to 75% of patients.
• FTSG Sensory Superiority: FTSGs recover superior tactile gnosis, with two-point discrimination frequently returning to within 2 to 4 mm of normal contralateral skin, making it the reconstruction of choice for tactile surfaces of digits.
• Adnexal and Autonomic Recovery: Sebaceous glands and hair follicles rarely survive in STSG, leaving the graft permanently dry, scaly, and prone to cracking, requiring lifelong daily application of emollient moisturizers. Sweating (eccrine function) recovers partially in FTSG if recipient bed reinnervation occurs.

Donor Site Re-Epithelialization and Long-Term Morbidity

• Re-Epithelialization Rates: Modern hydrofiber and polyurethane dressings achieve complete STSG donor site healing within a mean of 9.2 to 10.5 days for thin grafts and 12.0 to 14.5 days for medium grafts.
• Pain and Discomfort: Donor site pain is maximal during the first 48 to 72 hours and diminishes sharply once re-epithelialization is established.
• Cosmetic Sequelae: Long-term donor site morbidity includes permanent hypopigmentation or hyperpigmentation in up to 30% to 50% of patients, particularly in darker Fitzpatrick skin phototypes (Types IV-VI), and hypertrophic scar development in 5% to 15% of thick STSG harvests.

10. Complications

Complications following skin grafting are categorized chronologically into intraoperative technical misadventures, early postoperative graft failure modes, and late functional or cosmetic sequelae.

11. Pearls and Pitfalls

• Technical Pearl (The Two-Board Planar Glide): When harvesting from the anterolateral thigh, surface curvature and soft tissue laxity predispose to uneven harvest depth or gouging. Have an assistant press firmly 2 cm ahead of the dermatome using a mineral-oil-lubricated wooden tongue depressor or sterile board, while the operating surgeon applies reciprocal counter-traction 1 cm behind the dermatome. This flattens the thigh into a rigid planar surface, ensuring a uniform harvest thickness from start to finish.
• Technical Pearl (The Feeler Gauge Gap Verification): Never rely on the mechanical dial on an air or electric dermatome. Calibration drift and mechanical wear are common. Mechanically verify the cutting gap by sliding the spine of a standard #10 scalpel blade (thickness ~0.015 inches / 0.38 mm) into the aperture before activating the motor.
• Technical Pearl (Non-Adherent Interface Barrier under NPWT): Never apply black polyurethane foam directly onto a freshly placed skin graft. Capillary sprouts and granulating tissue will grow directly into the open pores of the foam within 48 to 72 hours, causing catastrophic avulsion and destruction of the graft when the sponge is stripped off at day 5. Always interpose a non-adherent, fenestrated silicone contact layer (such as Mepitel) or non-petrolatum porous mesh between the graft and the foam.
• Technical Pearl (The Immediate Epinephrine Sponge Pack): As soon as the dermatome passes the donor site, do not pause to inspect the harvest. Immediately compress the bleeding donor dermis with laparotomy sponges soaked in dilute epinephrine (1:100,000) or 1% lidocaine with epinephrine, covered with dry towels and firm two-handed manual pressure for a full 5 minutes. This halts capillary oozing, prevents extensive blood loss, and leaves a dry bed ready for modern dressing application.
• Technical Pearl (Staggered Slit Venting for Sheet Grafts): Even when applying an unmeshed sheet graft for optimal cosmetic or functional results on the hand or joint, always make 5 to 10 tiny, staggered 1 to 2 mm puncture slits with the tip of an 11-blade throughout the graft body. These vents allow microscopic hematomas to escape without compromising the final aesthetic or biomechanical architecture of the sheet graft.
• Judgment Pitfall (The Avascular Bone / Tendon Trap): Never place a skin graft directly onto dry cortical bone stripped of periosteum or tendon devoid of paratenon in the hope that it will survive. Skin grafts cannot create their own circulation; they require a pre-existing vascular bed. A graft placed over bare bone or tendon will necrose 100% of the time. Either burr the outer cortex down to punctate bleeding Haversian canals (microfracture technique), apply a bilayer dermal regeneration template for 3 to 4 weeks, or perform a local or microvascular free flap.
• Judgment Pitfall (Grafting Over Hyperemic or Congested Tissue): Attempting to graft an inflamed, edematous, dark-purple granulating bed. Venous hypertension and tissue congestion trigger immediate graft thrombosis and massive subgraft hematoma formation. Debride the bed back to healthy fascia or utilize staging NPWT at -125 mmHg for 48 to 72 hours to resolve congestion before applying the graft.
• Judgment Pitfall (Failure of Multi-Joint Immobilization): Neglecting to rigidly splint the joints proximal and distal to the graft. Subtle motion across the wrist, ankle, or knee creates microscopic shear forces that disrupt fragile fibrin bridges at 24 hours and shear budding capillary loops at 72 hours. Always immobilize the limb with a well-padded plaster or fiberglass splint in a position of function for at least 5 to 7 days.

12. Controversy

• Negative Pressure Wound Therapy (NPWT) Bolster vs Traditional Tie-Over Bolster: While traditional tie-over bolsters (secured with circumferential sutures tied over cotton or xeroform) have served as the historical standard, they suffer from significant limitations: uneven pressure distribution over complex contours, focal tissue necrosis at high-tension suture margins, and an inability to actively evacuate serosanguinous wound exudate. Modern NPWT bolsters apply continuous, uniform multidirectional negative pressure (-75 to -125 mmHg), continuously evacuate fluid, and rigidly immobilize the graft against the bed. Contemporary Level I evidence confirms superior graft take rates (OR 2.45), lower reoperation rates, and marked advantages in irregular, high-mobility anatomical beds. Controversy centers on cost-effectiveness: for small, flat, simple wounds (<5 to 10 cm²), traditional bolsters or simple non-adherent dressings are dramatically less expensive and achieve comparable take rates. Most reconstructive surgeons reserve NPWT bolsters for large (>20 cm²), irregular, high-mobility, or suboptimal recipient beds where graft loss would be catastrophic.
• Dermal Regeneration Templates (DRT) vs Flap Coverage for Exposed Bone and Tendon: Historically, soft tissue defects with exposed cortical bone devoid of periosteum or exposed tendon devoid of paratenon mandated pedicled or microvascular free tissue transfer (muscle or fasciocutaneous flaps). The development of bilayer acellular dermal matrices / dermal regeneration templates (e.g., Integra, Pelnac) combined with NPWT has established an alternative reconstructive pathway: the matrix provides a porous scaffold that vascularizes over 3 to 4 weeks, creating a neodermis capable of accepting a secondary STSG. The controversy lies in comparing the two paradigms: DRTs avoid donor site morbidity associated with major flap harvest (e.g., ALT or latissimus) and are technically simpler for non-microsurgeons; however, they require a two-stage surgical process, carry significant financial device costs, are highly vulnerable to catastrophic failure if colonized by bacteria, and lack the robust mechanical padding and long-term shear resistance of a vascularized muscle or fasciocutaneous flap over weight-bearing or joint-adjacent anatomy.
• Optimal Dressing Selection for Split-Thickness Donor Sites: Despite hundreds of comparative trials, universal consensus on the single ideal donor site dressing remains elusive. Historically, paraffin-impregnated or petroleum gauze (e.g., Jelonet, Xeroform) was the universal standard due to low direct unit cost; however, it dries into a rigid, adherent crust that causes intense patient pain and tears newly formed epithelial islands during removal, delaying healing. Contemporary Level I evidence strongly supports modern moisture-retentive semi-occlusive dressings, including silver-impregnated hydrofibers, polyurethane films, and calcium alginates. These dressings accelerate re-epithelialization by 3 to 5 days and significantly reduce patient-reported pain scores. The ongoing debate balances the higher initial material cost of advanced dressings against downstream savings from reduced nursing dressing changes and accelerated patient mobilization.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• Yin Y, Zhang R, Li S et al. Negative-pressure therapy versus conventional therapy on split-thickness skin graft: A systematic review and meta-analysis. Int J Surg. 2018. doi:10.1016/j.ijsu.2017.12.020 [Level I: Systematic Review / Meta-Analysis]
• Cao X, Hu Z, Zhang Y et al. Negative-Pressure Wound Therapy Improves Take Rate of Skin Graft in Irregular, High-Mobility Areas: A Randomized Controlled Trial. Plast Reconstr Surg. 2022. doi:10.1097/PRS.0000000000009704 [Level I: Randomized Controlled Trial]
• Seretis K, Bounas N. Securing skin grafts: A network meta-analysis. J Plast Reconstr Aesthet Surg. 2024. doi:10.1016/j.bjps.2024.07.005 [Level I: Systematic Review / Network Meta-Analysis]
• Guogienė I, Kievišas M, Grigaitė A et al. Split-thickness skin grafting: early outcomes of a clinical trial using different graft thickness. J Wound Care. 2018. doi:10.12968/jowc.2018.27.1.5 [Level I: Randomized Controlled Trial]
• Karlsson M, Lindgren M, Jarnhed-Andersson I et al. Dressing the split-thickness skin graft donor site: a randomized clinical trial. Adv Skin Wound Care. 2014. doi:10.1097/01.ASW.0000437786.92529.22 [Level I: Randomized Controlled Trial]

15. Master Class Pro-Tip

In orthopaedic trauma and reconstructive surgery, the primary determinant of skin graft take is the biological vascularity of the recipient bed, not the harvesting technique. Never attempt to graft over bare cortical bone devoid of periosteum, avascular tendon stripped of paratenon, or a dusky, congested granulating bed in the hope that a skin graft will somehow stimulate revascularization. If bare bone or tendon is exposed, either prepare the substrate with cortical fenestration down to bleeding Haversian canals combined with a staged dermal regeneration template and negative pressure therapy, or proceed directly to rotational or free muscle flap coverage. When harvesting, manually calibrate your dermatome aperture with a feeler gauge, maintain two-point counter-traction using mineral-oil-lubricated wooden boards to flatten the donor field, and select an intermediate harvest thickness of 0.012 to 0.014 inches. Always interpose a non-adherent fenestrated silicone contact layer beneath a continuous negative pressure bolster maintained at -100 to -125 mmHg, and rigidly immobilize the adjacent joints in a splint for 5 to 7 days to eliminate micro-shear across the inosculating capillary network.

Master Class Surgical Pearl: Skin Grafting and Soft Tissue Coverage